Pembrolizumab Plus Reduced Ipilimumab Dose Active in Advanced Melanoma

Standard-dose pembrolizumab with four reduced doses of ipilimumab followed by standard-dose pembrolizumab had a manageable safety profile and antitumor activity in patients with advanced melanoma.

Source: CancerNetwork - August 7, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Melanoma News Source Type: news